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Ubiquitous worldwide, coronaviruses are known to cause
serious and economically damaging respiratory, enteric
and neurologic diseases in animals such as cattle, pigs and
fowl. Since the mid-1960s, they are recognized human
respiratory pathogens involved in up to a third of infec-
tions of the upper respiratory tract, of the common cold
type. Even though they are suspected to cause more seri-
ous infections in humans, affecting the lower respiratory
and gastro-intestinal tracts, as well as the central nervous
system (CNS), this remained subject of investigations in
only a few laboratories. This changed dramatically in
2002–2003, when the Severe Acute Respiratory Syndrome
(SARS) epidemic swept the world, and was linked to a
coronavirus (SARS-CoV) that evolved in bats, before
being transmitted to humans in Southeast Asia, with
some reports of neurological involvement.
We have accumulated evidence that human coronaviruses
(HCoV) may cause neurologic disease after CNS neuroin-
vasion and persistence. Strain OC43 readily established
persistent infections of neural cell lines and acquired
mutations in the gene encoding the viral surface protein S,
which interacts with cellular receptors. Biologically
cloned emerging virus variants had mutations in the puta-
tive S receptor-binding domain, which correlated with the
ability to infect not only neurons, the main target cell
type, but also astrocytes. Four reproducibly observed S
mutations were introduced into an infectious cDNA clone
(rOC/ATCC) to yield rOC/U and the two recombinant
viruses were compared for the induced neuropathogenesis
in BALB/c mice. We found that susceptibility to rOC/U
infection was enhanced and mice showed hind limb
paralysis associated with spinal cord demyelination,
whereas rOC/ATCC induced encephalitis.
These results suggest that acquisition of discrete S muta-
tions after persistence of HCoV-OC43 in neural cells
results in modulation of neurovirulence and modified
neuropathology. This may have implications in our
understanding of coronavirus pathogenesis in humans,
and points to the need for global research, prevention and
intervention efforts targeting various infectious pathogens
that could unexpectedly cause a global threat.
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